BALAXI PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of BALAXI PHARMACEUTICALS have increased by 20.77% YoY .
The Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS has increased by 5.48 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
BALAXI PHARMACEUTICALS Last 5 Annual Financial Results
[NSE : BALAXI]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹279 Cr | ₹231 Cr | ₹46 Cr | ₹1,360 Cr | ₹14 Cr |
| Expenses | ₹229 Cr | ₹189 Cr | ₹37 Cr | ₹1,204 Cr | ₹12 Cr |
| Operating Profit (Excl OI) | ₹51 Cr | ₹43 Cr | ₹8.25 Cr | ₹156 Cr | ₹1.56 Cr |
| Other Income | ₹4.97 Cr | ₹2.23 Cr | ₹0.60 Cr | ₹89 Cr | ₹0.89 Cr |
| Interest | ₹0.76 Cr | ₹0.28 Cr | ₹0.05 Cr | ₹0.23 Cr | ₹0.00 Cr |
| Depreciation | ₹0.51 Cr | ₹0.30 Cr | ₹0.01 Cr | ₹0.35 Cr | ₹0.00 Cr |
| Profit Before Tax | ₹55 Cr | ₹44 Cr | ₹8.79 Cr | ₹244 Cr | ₹2.44 Cr |
| Profit After Tax | ₹48 Cr | ₹38 Cr | ₹6.10 Cr | ₹197 Cr | ₹1.97 Cr |
| Consolidated Net Profit | ₹48 Cr | ₹37 Cr | ₹6.13 Cr | ₹197 Cr | ₹1.97 Cr |
| Earnings Per Share (Rs) | ₹50.82 | ₹48.18 | ₹37.23 | ₹6.10 | ₹6.47 |
| PAT Margin (%) | 13.66 | 17.06 | 16.49 | 13.38 | 14.46 |
| ROE(%) | 32.17 | 53.50 | 82.26 | 39.04 | 55.84 |
| ROCE(%) | 37.46 | 59.62 | 92.56 | 56.56 | 69.35 |
| Total Debt/Equity(x) | 0.07 | 0.03 | 0.06 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 628.8 Cr |
| Revenue (TTM) | : | ₹ 262.1 Cr |
| Net Profit(TTM) | : | ₹ -5.2 Cr |
| EPS (TTM) | : | ₹ -4.7 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BALAXI PHARMACEUTICALS | -3.3% | -20% | -5.4% |
| ADANI ENTERPRISES | 1.8% | -4.9% | 70.2% |
| REDINGTON | 2.5% | -1.3% | 27% |
| HONASA CONSUMER | NA | NA | NA |
| MMTC | 1.5% | -21.7% | 117.1% |
| MSTC | 1.9% | -10.7% | 225.8% |
| LLOYDS ENTERPRISES | NA | NA | NA |
| VERITAS (INDIA) | 8.2% | 40.5% | 537.8% |
| NOVARTIS INDIA | 3.9% | 2.7% | 80.7% |
BALAXI PHARMACEUTICALS Revenues
[NSE : BALAXI]
| Y-o-Y | 20.77 % |
| 5 Yr CAGR | 112.92 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹279 Cr | 20.77 | |
| Mar2022 | ₹231 Cr | 406.94 | |
| Mar2021 | ₹46 Cr | -96.64 | |
| Mar2020 | ₹1,360 Cr | 9,900.29 | |
| Mar2019 | ₹14 Cr | - | |
BALAXI PHARMACEUTICALS Operating Profit
[NSE : BALAXI]
| Y-o-Y | 19.08 % |
| 5 Yr CAGR | 138.95 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹51 Cr | 19.08 | |
| Mar2022 | ₹43 Cr | 417.06 | |
| Mar2021 | ₹8.25 Cr | -94.70 | |
| Mar2020 | ₹156 Cr | 9,897.43 | |
| Mar2019 | ₹1.56 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -1.41 % |
| 5 Yr CAGR | 12.22 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 18.19% | -1.41 | |
| Mar2022 | 18.45% | 1.99 | |
| Mar2021 | 18.09% | 57.85 | |
| Mar2020 | 11.46% | -0.09 | |
| Mar2019 | 11.47% | - | |
BALAXI PHARMACEUTICALS Profit After Tax
[NSE : BALAXI]
| Y-o-Y | 29.41 % |
| 5 Yr CAGR | 122.50 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹48 Cr | 29.41 | |
| Mar2022 | ₹37 Cr | 507.51 | |
| Mar2021 | ₹6.13 Cr | -96.88 | |
| Mar2020 | ₹197 Cr | 9,899.49 | |
| Mar2019 | ₹1.97 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -19.93 % |
| 5 Yr CAGR | -1.41 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 13.66 % | -19.93 | |
| Mar2022 | 17.06 % | 3.46 | |
| Mar2021 | 16.49 % | 23.24 | |
| Mar2020 | 13.38 % | -7.47 | |
| Mar2019 | 14.46 % | - | |
BALAXI PHARMACEUTICALS Earnings Per Share (EPS)
[NSE : BALAXI]
| Y-o-Y | 5.48 % |
| 5 Yr CAGR | 67.41 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹51 | 5.48 | |
| Mar2022 | ₹48 | 29.41 | |
| Mar2021 | ₹37 | 510.33 | |
| Mar2020 | ₹6.10 | -5.72 | |
| Mar2019 | ₹6.47 | - | |
BALAXI PHARMACEUTICALS Return on Capital Employed (ROCE)
[NSE : BALAXI]
| Y-o-Y | -37.17 % |
| 5 Yr CAGR | -14.27 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 37.46% | -37.17 | |
| Mar2022 | 59.62% | -35.59 | |
| Mar2021 | 92.56% | 63.65 | |
| Mar2020 | 56.56% | -18.44 | |
| Mar2019 | 69.35% | - | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹571.6 |
| Current MarketCap | : | ₹ 628.8 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -3.3% |
-20% |
-5.4% |
| SENSEX | 1.3% |
2.6% |
24% |
BALAXI PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about BALAXI PHARMACEUTICALS Financials
How the annual revenues of BALAXI PHARMACEUTICALS have changed ?
The Revenues of BALAXI PHARMACEUTICALS have increased by 20.77% YoY .
How the Earnings per Share (EPS) of BALAXI PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS has increased by 5.48 % YoY .
Check out Intrinsic Value of Peers of BALAXI PHARMACEUTICALS
|
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of REDINGTON LTD Intrinsic Value of HONASA CONSUMER LTD Intrinsic Value of MMTC LTD Intrinsic Value of MSTC LTD |
Compare Stock Analytics of Peers of BALAXI PHARMACEUTICALS
ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs
ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs
